PROVIDER PROFILE · NPI 1023345998
Rocio NaranjoP.A.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
483
Unique beneficiaries
—
Total services
1,878
Distinct HCPCS
12
Medicare payment
$32K
PRESCRIBING · PART D · 2024
Total Rx claims
708
Beneficiaries
—
Total drug cost
$91K
Distinct drugs
19
Brand share
33.1%
Top prescribed drugs
Fluticasone Propionate94 claims
Azelastine Hcl76 claims
Famotidine72 claims
Fluticasone/Umeclidin/Vilanter68 claims
Albuterol Sulfate59 claims
QUALITY · MIPS · 2024
Final MIPS score
93.2
Quality
88.6
Cost
75.4
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.77%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$773
Payment records
47
By payment type
Food and Beverage$732
Education$41
Top paying entities
Food and Beverage$732
Education$41
REFERRAL NETWORK
Where Rocio Naranjo's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 2 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Muhammad Bashir Allergy/ Immunology · Palo Alto, CA | 17 | 52 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Angela Sabry Allergy/ Immunology · Fresno, CA | 13 | 57 |
| Muhammad Bashir Allergy/ Immunology · Palo Alto, CA | 12 | 34 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE